{
  "id": [
    "25209969"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "25209969"
  ],
  "pmcid": [
    "PMC4226719"
  ],
  "title": [
    "Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer."
  ],
  "authorString": [
    "Dobbin ZC, Katre AA, Steg AD, Erickson BK, Shah MM, Alvarez RD, Conner MG, Schneider D, Chen D, Landen CN."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Dobbin ZC"
          ],
          "firstName": [
            "Zachary C"
          ],
          "lastName": [
            "Dobbin"
          ],
          "initials": [
            "ZC"
          ],
          "affiliation": [
            "Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham. NIH Medical Scientist Training Program, University of Alabama at Birmingham."
          ]
        },
        {
          "fullName": [
            "Katre AA"
          ],
          "firstName": [
            "Ashwini A"
          ],
          "lastName": [
            "Katre"
          ],
          "initials": [
            "AA"
          ],
          "affiliation": [
            "Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham."
          ]
        },
        {
          "fullName": [
            "Steg AD"
          ],
          "firstName": [
            "Adam D"
          ],
          "lastName": [
            "Steg"
          ],
          "initials": [
            "AD"
          ],
          "affiliation": [
            "Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham."
          ]
        },
        {
          "fullName": [
            "Erickson BK"
          ],
          "firstName": [
            "Britt K"
          ],
          "lastName": [
            "Erickson"
          ],
          "initials": [
            "BK"
          ],
          "affiliation": [
            "Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham."
          ]
        },
        {
          "fullName": [
            "Shah MM"
          ],
          "firstName": [
            "Monjri M"
          ],
          "lastName": [
            "Shah"
          ],
          "initials": [
            "MM"
          ],
          "affiliation": [
            "Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham."
          ]
        },
        {
          "fullName": [
            "Alvarez RD"
          ],
          "firstName": [
            "Ronald D"
          ],
          "lastName": [
            "Alvarez"
          ],
          "initials": [
            "RD"
          ],
          "affiliation": [
            "Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham."
          ]
        },
        {
          "fullName": [
            "Conner MG"
          ],
          "firstName": [
            "Michael G"
          ],
          "lastName": [
            "Conner"
          ],
          "initials": [
            "MG"
          ],
          "affiliation": [
            "Department of Pathology, University of Alabama at Birmingham."
          ]
        },
        {
          "fullName": [
            "Schneider D"
          ],
          "firstName": [
            "David"
          ],
          "lastName": [
            "Schneider"
          ],
          "initials": [
            "D"
          ],
          "affiliation": [
            "Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham."
          ]
        },
        {
          "fullName": [
            "Chen D"
          ],
          "firstName": [
            "Dongquan"
          ],
          "lastName": [
            "Chen"
          ],
          "initials": [
            "D"
          ],
          "affiliation": [
            "Division of Preventative Medicine, Department of Medicine, University of Alabama at Birmingham."
          ]
        },
        {
          "fullName": [
            "Landen CN"
          ],
          "firstName": [
            "Charles N"
          ],
          "lastName": [
            "Landen"
          ],
          "initials": [
            "CN"
          ],
          "affiliation": [
            "Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The University of Virginia, Charlottesville, VA."
          ]
        }
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "18"
      ],
      "volume": [
        "5"
      ],
      "journalIssueId": [
        "2212213"
      ],
      "dateOfPublication": [
        "2014 Sep"
      ],
      "monthOfPublication": [
        "9"
      ],
      "yearOfPublication": [
        "2014"
      ],
      "printPublicationDate": [
        "2014-09-01"
      ],
      "journal": [
        {
          "title": [
            "Oncotarget"
          ],
          "ISOAbbreviation": [
            "Oncotarget"
          ],
          "medlineAbbreviation": [
            "Oncotarget"
          ],
          "NLMid": [
            "101532965"
          ],
          "ESSN": [
            "1949-2553"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2014"
  ],
  "pageInfo": [
    "8750-8764"
  ],
  "abstractText": [
    "A cornerstone of preclinical cancer research has been the use of clonal cell lines. However, this resource has underperformed in its ability to effectively identify novel therapeutics and evaluate the heterogeneity in a patient's tumor. The patient-derived xenograft (PDX) model retains the heterogeneity of patient tumors, allowing a means to not only examine efficacy of a therapy, but also basic tenets of cancer biology in response to treatment. Herein we describe the development and characterization of an ovarian-PDX model in order to study the development of chemoresistance. We demonstrate that PDX tumors are not simply composed of tumor-initiating cells, but recapitulate the original tumor's heterogeneity, oncogene expression profiles, and clinical response to chemotherapy. Combined carboplatin/paclitaxel treatment of PDX tumors enriches the cancer stem cell populations, but persistent tumors are not entirely composed of these populations. RNA-Seq analysis of six pair of treated PDX tumors compared to untreated tumors demonstrates a consistently contrasting genetic profile after therapy, suggesting similar, but few, pathways are mediating chemoresistance. Pathways and genes identified by this methodology represent novel approaches to targeting the chemoresistant population in ovarian cancer."
  ],
  "affiliation": [
    "Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham. NIH Medical Scientist Training Program, University of Alabama at Birmingham."
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Print"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "Journal Article",
        "Research Support, Non-U.S. Gov't",
        "Research Support, U.S. Gov't, Non-P.H.S.",
        "Research Support, N.I.H., Extramural"
      ]
    }
  ],
  "grantsList": [
    {
      "grant": [
        {
          "grantId": [
            "5UL1RR025777"
          ],
          "agency": [
            "NCRR NIH HHS"
          ],
          "acronym": [
            "RR"
          ],
          "orderIn": [
            "0"
          ]
        },
        {
          "grantId": [
            "R01 GM084946"
          ],
          "agency": [
            "NIGMS NIH HHS"
          ],
          "acronym": [
            "GM"
          ],
          "orderIn": [
            "0"
          ]
        },
        {
          "grantId": [
            "UL1 RR025777"
          ],
          "agency": [
            "NCRR NIH HHS"
          ],
          "acronym": [
            "RR"
          ],
          "orderIn": [
            "0"
          ]
        },
        {
          "grantId": [
            "T32GM008361"
          ],
          "agency": [
            "NIGMS NIH HHS"
          ],
          "acronym": [
            "GM"
          ],
          "orderIn": [
            "0"
          ]
        },
        {
          "grantId": [
            "T32 GM008361"
          ],
          "agency": [
            "NIGMS NIH HHS"
          ],
          "acronym": [
            "GM"
          ],
          "orderIn": [
            "0"
          ]
        }
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Animals"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Humans"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Mice, SCID"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Ovarian Neoplasms"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "GE"
                  ],
                  "qualifierName": [
                    "genetics"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "ME"
                  ],
                  "qualifierName": [
                    "metabolism"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "PA"
                  ],
                  "qualifierName": [
                    "pathology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Antineoplastic Agents"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "PD"
                  ],
                  "qualifierName": [
                    "pharmacology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Tumor Burden"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DE"
                  ],
                  "qualifierName": [
                    "drug effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Immunohistochemistry"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Predictive Value of Tests"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Xenograft Model Antitumor Assays"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Gene Expression Profiling"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Polymerase Chain Reaction"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Neoplasm Transplantation"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Gene Expression Regulation, Neoplastic"
          ]
        },
        {
          "majorTopic_YN": [
            "Y"
          ],
          "descriptorName": [
            "Drug Resistance, Neoplasm"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "GE"
                  ],
                  "qualifierName": [
                    "genetics"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Patient Selection"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Time Factors"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Aged"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Aged, 80 and over"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Middle Aged"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Female"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Gene Regulatory Networks"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Neoplastic Stem Cells"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DE"
                  ],
                  "qualifierName": [
                    "drug effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "ME"
                  ],
                  "qualifierName": [
                    "metabolism"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "PA"
                  ],
                  "qualifierName": [
                    "pathology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "High-Throughput Nucleotide Sequencing"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Biomarkers, Tumor"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "GE"
                  ],
                  "qualifierName": [
                    "genetics"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "ME"
                  ],
                  "qualifierName": [
                    "metabolism"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Precision Medicine"
          ]
        }
      ]
    }
  ],
  "chemicalList": [
    {
      "chemical": [
        {
          "name": [
            "Antineoplastic Agents"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Biomarkers, Tumor"
          ],
          "registryNumber": [
            "0"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "http://europepmc.org/articles/PMC4226719?pdf=render"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "http://europepmc.org/articles/PMC4226719"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "Y"
  ],
  "citedByCount": [
    "15"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "license": [
    "cc by"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCompletion": [
    "2015-06-25"
  ],
  "dateOfCreation": [
    "2014-10-16"
  ],
  "dateOfRevision": [
    "2016-10-19"
  ],
  "firstPublicationDate": [
    "2014-09-01"
  ]
}